Literature DB >> 25707981

No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine.

Dominic Docter1, Sebastian Strieth, Dana Westmeier, Oliver Hayden, Mingyuan Gao, Shirley K Knauer, Roland H Stauber.   

Abstract

Besides the wide use of nanomaterials in technical products, their application spectrum in biotechnology and biomedicine is steadily increasing. Whereas the physico-chemical properties and behavior of nanomaterials can be engineered and characterized accurately under idealized conditions, this is no longer the case in complex physiological environments. In biological fluids, proteins rapidly bind to nanomaterials forming the protein corona, critically affecting the nanomaterials' biological identity. As the corona impacts in vitro and/or in vivo nanomaterial applications, we here review the concept of the protein corona and its analytical dissection. We comment on how corona signatures may be linked to effects at the nano-bio interface and conclude how such knowledge is offering novel opportunities for improved nanomedicine.

Entities:  

Keywords:  bioinformatics; blood system; colloidal chemistry; label-free quantification; mass spectrometry; nanomaterials; nanomedicine; nanotoxicology; proteomics

Mesh:

Substances:

Year:  2015        PMID: 25707981     DOI: 10.2217/nnm.14.184

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  21 in total

Review 1.  Tissue Specific Fate of Nanomaterials by Advanced Analytical Imaging Techniques - A Review.

Authors:  Uschi M Graham; Alan K Dozier; Günter Oberdörster; Robert A Yokel; Ramon Molina; Joseph D Brain; Jayant M Pinto; Jennifer Weuve; David A Bennett
Journal:  Chem Res Toxicol       Date:  2020-05-12       Impact factor: 3.739

2.  Nanoparticle decoration impacts airborne fungal pathobiology.

Authors:  Dana Westmeier; Djamschid Solouk-Saran; Cecilia Vallet; Svenja Siemer; Dominic Docter; Hermann Götz; Linda Männ; Anja Hasenberg; Angelina Hahlbrock; Kathrin Erler; Christoph Reinhardt; Oliver Schilling; Sven Becker; Matthias Gunzer; Mike Hasenberg; Shirley K Knauer; Roland H Stauber
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-20       Impact factor: 11.205

Review 3.  From Dose to Response: In Vivo Nanoparticle Processing and Potential Toxicity.

Authors:  Uschi M Graham; Gary Jacobs; Robert A Yokel; Burtron H Davis; Alan K Dozier; M Eileen Birch; Michael T Tseng; Günter Oberdörster; Alison Elder; Lisa DeLouise
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  Concentration and composition of the protein corona as a function of incubation time and serum concentration: an automated approach to the protein corona.

Authors:  Karsten M Poulsen; Christine K Payne
Journal:  Anal Bioanal Chem       Date:  2022-08-26       Impact factor: 4.478

5.  Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.

Authors:  Nenad L Ignjatović; Katarina M Penov-Gaši; Victoria M Wu; Jovana J Ajduković; Vesna V Kojić; Dana Vasiljević-Radović; Maja Kuzmanović; Vuk Uskoković; Dragan P Uskoković
Journal:  Colloids Surf B Biointerfaces       Date:  2016-09-28       Impact factor: 5.268

Review 6.  The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.

Authors:  Claudia Corbo; Roberto Molinaro; Alessandro Parodi; Naama E Toledano Furman; Francesco Salvatore; Ennio Tasciotti
Journal:  Nanomedicine (Lond)       Date:  2015-12-11       Impact factor: 5.307

Review 7.  Taspase1: a 'misunderstood' protease with translational cancer relevance.

Authors:  D Wünsch; A Hahlbrock; S Jung; T Schirmeister; J van den Boom; O Schilling; S K Knauer; R H Stauber
Journal:  Oncogene       Date:  2015-12-14       Impact factor: 9.867

Review 8.  Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer.

Authors:  P S Thakur; A M Khan; S Talegaonkar; F J Ahmad; Z Iqbal
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-26       Impact factor: 4.553

Review 9.  Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles.

Authors:  Jeremy P Bost; Hanna Barriga; Margaret N Holme; Audrey Gallud; Marco Maugeri; Dhanu Gupta; Taavi Lehto; Hadi Valadi; Elin K Esbjörner; Molly M Stevens; Samir El-Andaloussi
Journal:  ACS Nano       Date:  2021-09-10       Impact factor: 15.881

10.  Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages.

Authors:  Carmen Vogt; Maria Pernemalm; Pekka Kohonen; Sophie Laurent; Kjell Hultenby; Marie Vahter; Janne Lehtiö; Muhammet S Toprak; Bengt Fadeel
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.